223 related articles for article (PubMed ID: 25099079)
1. Recombinant human erythropoietin to target cognitive dysfunction in bipolar disorder: a double-blind, randomized, placebo-controlled phase 2 trial.
Miskowiak KW; Ehrenreich H; Christensen EM; Kessing LV; Vinberg M
J Clin Psychiatry; 2014 Dec; 75(12):1347-55. PubMed ID: 25099079
[TBL] [Abstract][Full Text] [Related]
2. Effects of recombinant human erythropoietin on cognition and neural activity in remitted patients with mood disorders and first-degree relatives of patients with psychiatric disorders: a study protocol for a randomized controlled trial.
Petersen JZ; Schmidt LS; Vinberg M; Jørgensen MB; Hageman I; Ehrenreich H; Knudsen GM; Kessing LV; Miskowiak KW
Trials; 2018 Nov; 19(1):611. PubMed ID: 30400939
[TBL] [Abstract][Full Text] [Related]
3. Randomized placebo-controlled adjunctive study of an extract of withania somnifera for cognitive dysfunction in bipolar disorder.
Chengappa KN; Bowie CR; Schlicht PJ; Fleet D; Brar JS; Jindal R
J Clin Psychiatry; 2013 Nov; 74(11):1076-83. PubMed ID: 24330893
[TBL] [Abstract][Full Text] [Related]
4. Targeting Treatments to Improve Cognitive Function in Mood Disorder: Suggestions From Trials Using Erythropoietin.
Miskowiak KW; Rush AJ; Gerds TA; Vinberg M; Kessing LV
J Clin Psychiatry; 2016 Dec; 77(12):e1639-e1646. PubMed ID: 27835716
[TBL] [Abstract][Full Text] [Related]
5. Effects of erythropoietin on depressive symptoms and neurocognitive deficits in depression and bipolar disorder.
Miskowiak KW; Vinberg M; Harmer CJ; Ehrenreich H; Knudsen GM; Macoveanu J; Hansen AR; Paulson OB; Siebner HR; Kessing LV
Trials; 2010 Oct; 11():97. PubMed ID: 20942940
[TBL] [Abstract][Full Text] [Related]
6. Neural correlates of improved executive function following erythropoietin treatment in mood disorders.
Miskowiak KW; Vinberg M; Glerup L; Paulson OB; Knudsen GM; Ehrenreich H; Harmer CJ; Kessing LV; Siebner HR; Macoveanu J
Psychol Med; 2016 Jun; 46(8):1679-91. PubMed ID: 26996196
[TBL] [Abstract][Full Text] [Related]
7. Effects of Erythropoietin on Hippocampal Volume and Memory in Mood Disorders.
Miskowiak KW; Vinberg M; Macoveanu J; Ehrenreich H; Køster N; Inkster B; Paulson OB; Kessing LV; Skimminge A; Siebner HR
Biol Psychiatry; 2015 Aug; 78(4):270-7. PubMed ID: 25641635
[TBL] [Abstract][Full Text] [Related]
8. Recombinant human erythropoietin for treating treatment-resistant depression: a double-blind, randomized, placebo-controlled phase 2 trial.
Miskowiak KW; Vinberg M; Christensen EM; Bukh JD; Harmer CJ; Ehrenreich H; Kessing LV
Neuropsychopharmacology; 2014 May; 39(6):1399-408. PubMed ID: 24322509
[TBL] [Abstract][Full Text] [Related]
9. Neural correlates of improved recognition of happy faces after erythropoietin treatment in bipolar disorder.
Miskowiak KW; Petersen NA; Harmer CJ; Ehrenreich E; Kessing LV; Vinberg M; Macoveanu J; Siebner HR
Acta Psychiatr Scand; 2018 Oct; 138(4):336-347. PubMed ID: 29882276
[TBL] [Abstract][Full Text] [Related]
10. Erythropoietin as an add-on treatment for cognitive side effects of electroconvulsive therapy: a study protocol for a randomized controlled trial.
Schmidt LS; Petersen JZ; Vinberg M; Hageman I; Olsen NV; Kessing LV; Jørgensen MB; Miskowiak KW
Trials; 2018 Apr; 19(1):234. PubMed ID: 29673379
[TBL] [Abstract][Full Text] [Related]
11. A randomized, double-blind, controlled trial evaluating the effect of intranasal insulin on neurocognitive function in euthymic patients with bipolar disorder.
McIntyre RS; Soczynska JK; Woldeyohannes HO; Miranda A; Vaccarino A; Macqueen G; Lewis GF; Kennedy SH
Bipolar Disord; 2012 Nov; 14(7):697-706. PubMed ID: 23107220
[TBL] [Abstract][Full Text] [Related]
12. Effects of cognitive remediation on cognitive dysfunction in partially or fully remitted patients with bipolar disorder: study protocol for a randomized controlled trial.
Demant KM; Almer GM; Vinberg M; Kessing LV; Miskowiak KW
Trials; 2013 Nov; 14():378. PubMed ID: 24206639
[TBL] [Abstract][Full Text] [Related]
13. A randomized, placebo-controlled trial of citicoline add-on therapy in outpatients with bipolar disorder and cocaine dependence.
Brown ES; Gorman AR; Hynan LS
J Clin Psychopharmacol; 2007 Oct; 27(5):498-502. PubMed ID: 17873684
[TBL] [Abstract][Full Text] [Related]
14. 12-month longitudinal cognitive functioning in patients recently diagnosed with bipolar disorder.
Torres IJ; Kozicky J; Popuri S; Bond DJ; Honer WG; Lam RW; Yatham LN
Bipolar Disord; 2014 Mar; 16(2):159-71. PubMed ID: 24636366
[TBL] [Abstract][Full Text] [Related]
15. Improvements in neurocognitive function and mood following adjunctive treatment with mifepristone (RU-486) in bipolar disorder.
Young AH; Gallagher P; Watson S; Del-Estal D; Owen BM; Ferrier IN
Neuropsychopharmacology; 2004 Aug; 29(8):1538-45. PubMed ID: 15127079
[TBL] [Abstract][Full Text] [Related]
16. Nicotine fails to attenuate ketamine-induced cognitive deficits and negative and positive symptoms in humans: implications for schizophrenia.
D'Souza DC; Ahn K; Bhakta S; Elander J; Singh N; Nadim H; Jatlow P; Suckow RF; Pittman B; Ranganathan M
Biol Psychiatry; 2012 Nov; 72(9):785-94. PubMed ID: 22717030
[TBL] [Abstract][Full Text] [Related]
17. Effect of recombinant erythropoietin on inflammatory markers in patients with affective disorders: A randomised controlled study.
Vinberg M; Weikop P; Olsen NV; Kessing LV; Miskowiak K
Brain Behav Immun; 2016 Oct; 57():53-57. PubMed ID: 27181179
[TBL] [Abstract][Full Text] [Related]
18. Long-term stability of cognitive impairment in bipolar disorder: a 2-year follow-up study of lithium-treated euthymic bipolar patients.
Mur M; Portella MJ; Martínez-Arán A; Pifarré J; Vieta E
J Clin Psychiatry; 2008 May; 69(5):712-9. PubMed ID: 18435565
[TBL] [Abstract][Full Text] [Related]
19. Placebo-controlled adjunctive trial of pramipexole in patients with bipolar disorder: targeting cognitive dysfunction.
Burdick KE; Braga RJ; Nnadi CU; Shaya Y; Stearns WH; Malhotra AK
J Clin Psychiatry; 2012 Jan; 73(1):103-12. PubMed ID: 22152405
[TBL] [Abstract][Full Text] [Related]
20. Erythropoietin for Cognitive Deficits Associated with Schizophrenia, Bipolar Disorder, and Major Depression: A Systematic Review.
Li XB; Zheng W; Ning YP; Cai DB; Yang XH; Ungvari GS; Ng CH; Wang CY; Xiang YT
Pharmacopsychiatry; 2018 May; 51(3):100-104. PubMed ID: 28718181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
